SAMHSA is accepting applications for Medication-Assisted Treatment Prescription Drug and Opioid Addiction (MAT-PDOA) grants. The purpose of this program is to expand/enhance access to medication-assisted treatment (MAT) services for persons with an opioid use disorder seeking or receiving MAT.
SAMHSA plans to issue approximately 89 to 135 awards of up to $1 million per year for states and up to $525,000 per year for other domestic public or non-profit entities for up to 5 years.
The COVID-19 Telehealth Program provides funding to eligible health care providers responding to the COVID-19 pandemic to support the telecommunications services, information services, and connected devices needed to provide critical connected care. The program – established in the Coronavirus Aid, Relief, and Economic Security (CARES) Act – provided $200 million in funding to help health care providers provide telehealth and connected care services to patients at their homes or mobile locations in response to the COVID-19 pandemic.
2021: Second Round of Funding
The Consolidated Appropriations Act (CAA) provided an additional $249.95 million to fund a second round of the COVID-19 Telehealth Program. Congress directed the Federal Communications Commission (FCC) to seek comment on how to commit the new funding.
On March 30, the FCC released a Report and Order setting forth details about the second round of the COVID-19 Telehealth Program. In February, the FCC found it was in the public interest to use the Universal Service Administrative Company (USAC) to administer the program’s second round.
On April 15, the FCC released a Public Notice announcing that the application window for the second round of COVID-19 Telehealth funding will open on April 29. Interested applicants can participate in a series of trainings before the application window to prepare.
The purpose of this program is to enable community mental health centers to support and restore the delivery of clinical services that were impacted by the COVID-19 pandemic and effectively address the needs of individuals with serious emotional disturbance (SED), serious mental illness (SMI), and individuals with SMI or SED and substance use disorders, referred to as co-occurring disorder (COD). SAMHSA recognizes the needs of individuals with behavioral health conditions, including minority populations and economically disadvantaged communities, have not been met during the pandemic and that CMHC staff and other caregivers have been impacted.
Awards will be between $1m and $5m over two years (depending on population size). SAMHSA anticipates making between 165 and 825 awards.
According to SAMHSA, if the provider is not a CMHC but meets the 1913(c) criteria of the Public Health Services (PHS) Act, and as long as the provider is licensed/certified by the state or any nationally recognized accreditation organization, the provider can apply.